Lewy body dementia (LBD) is the second most common cause of progressive dementia, impacting an estimated 1.4 million people in the United States. Despite the condition’s prevalence, LBD is the most often misdiagnosed type of dementia, and is misunderstood by many clinicians. A recent survey by the Lewy Body Dementia Association (LBDA) of people with LBD and care partners found that despite interest in rehabilitation services, most people do not receive access to rehabilitation services during their journey with LBD. It’s time to…

Lewy body dementia (LBD) is the second most common cause of progressive dementia, impacting an estimated 1.4 million people in the United States. Despite the condition’s prevalence, LBD is the most often misdiagnosed type of dementia, and is misunderstood by many clinicians. A recent survey by the Lewy Body Dementia Association (LBDA) of people with LBD and care partners found that despite interest in rehabilitation services, most people do not receive access to rehabilitation services during their journey with LBD. It’s time to…

Deep Brain Stimulation (DBS) has revolutionized the treatment of movement disorders, yet challenges in communication and mobility often persist. This webinar will demonstrate how LSVT LOUD® and LSVT BIG® can maximize communication and mobility outcomes, offering invaluable insights for healthcare professionals, researchers, caregivers, and those considering DBS as a treatment option. Delve into the science and methodology behind these evidence-based approaches, and learn how they can empower individuals post-DBS to regain effective communication skills and optimize mobility. Research and real-life…